Cano Health Inc (CANO) Stock: Do Analysts Think You Should Sell?

Friday, January 20, 2023 12:14 PM | InvestorsObserver Analysts

Mentioned in this article

Cano Health Inc (CANO) Stock: Do Analysts Think You Should Sell?

Wall Street is positive on Cano Health Inc (CANO). On average, analysts give CANO a Buy rating. The average price target is $4.556, which means analysts expect the stock to increase by 230.14% over the next twelve months. That average ranking earns CANO an Analyst Rating of 14, which is better than 14% of stocks based on data compiled by InvestorsObserver.

Wall Street analysts are rating CANO a Buy today. Find out what this means to you and get the rest of the rankings on CANO!

See Full CANO Report

Why are Analyst Ratings Important?

Fundamental research of the underlying health of a company can be an extremely useful resource when making investment decisions. Analysts observe growth prospects and forecasted earnings of companies to gain a comprehensive view of particular industries. This data allows traders to react before numbers are officially reported. InvestorsObserver takes the ratings from these analysts and percentile ranks those aveages. This allows you to compare stocks extensively and in more detail than the common buy/hold/sell ratings.

What's Happening With Cano Health Inc Stock Today?

Cano Health Inc (CANO) stock is trading at $1.38 as of 12:04 PM on Friday, Jan 20, a rise of $0.04, or 2.99% from the previous closing price of $1.34. The stock has traded between $1.34 and $1.46 so far today. Volume today is below average. So far 2,735,502 shares have traded compared to average volume of 9,600,751 shares. Click Here to get the full Stock Report for Cano Health Inc stock.